T1	PROC 46 56	Evaluación
#1	AnnotatorNotes T1	C1261322; Evaluation procedure; Health Care Activity
T2	PROC 63 72	protocolo
#2	AnnotatorNotes T2	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T3	DISO 119 138	Artritis Reumatoide
#3	AnnotatorNotes T3	C0003873; Rheumatoid Arthritis; Disease or Syndrome
T4	DISO 140 142	AR
#4	AnnotatorNotes T4	C0003873; Rheumatoid Arthritis; Disease or Syndrome
T5	PROC 167 202	tratamiento con terapias biológicas
T6	PROC 225 235	Evaluación
#5	AnnotatorNotes T6	C1261322; Evaluation procedure; Health Care Activity
T7	PROC 265 288	protocolo estandarizado
T8	DISO 350 369	Artritis Reumatoide
#6	AnnotatorNotes T8	C0003873; Rheumatoid Arthritis; Disease or Syndrome
T9	DISO 371 373	AR
#7	AnnotatorNotes T9	C0003873; Rheumatoid Arthritis; Disease or Syndrome
T10	PROC 410 445	tratamiento con terapias biológicas
T11	PROC 447 489	Estudio abierto, controlado y aleatorizado
T12	PROC 513 523	Evaluación
#8	AnnotatorNotes T12	C1261322; Evaluation procedure; Health Care Activity
T13	PROC 530 539	protocolo
#9	AnnotatorNotes T13	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T14	DISO 586 605	Artritis Reumatoide
#10	AnnotatorNotes T14	C0003873; Rheumatoid Arthritis; Disease or Syndrome
T15	PROC 620 655	tratamiento con terapias biológicas
T16	PROC 682 692	Evaluación
#11	AnnotatorNotes T16	C1261322; Evaluation procedure; Health Care Activity
T17	PROC 722 745	protocolo estandarizado
T18	DISO 807 826	Artritis Reumatoide
#12	AnnotatorNotes T18	C0003873; Rheumatoid Arthritis; Disease or Syndrome
T19	PROC 849 884	tratamiento con terapias biológicas
T20	DISO 959 978	Artritis Reumatoide
#13	AnnotatorNotes T20	C0003873; Rheumatoid Arthritis; Disease or Syndrome
T21	DISO 980 982	AR
#14	AnnotatorNotes T21	C0003873; Rheumatoid Arthritis; Disease or Syndrome
T22	PROC 1055 1088	tratamiento con terapia biológica
T23	CHEM 1090 1100	infliximab
#15	AnnotatorNotes T23	C0666743; infliximab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T24	CHEM 1102 1112	adalimumab
#16	AnnotatorNotes T24	C1122087; adalimumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T25	CHEM 1114 1124	etanercept
#17	AnnotatorNotes T25	C0717758; etanercept; Amino Acid, Peptide, or Protein · Pharmacologic Substance
T26	CHEM 1126 1135	golimumab
#18	AnnotatorNotes T26	C2353893; golimumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T27	CHEM 1137 1149	certolizumab
#19	AnnotatorNotes T27	C1872109; certolizumab pegol; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T28	CHEM 1151 1160	abatacept
#20	AnnotatorNotes T28	C1619966; abatacept; Amino Acid, Peptide, or Protein · Pharmacologic Substance
T29	CHEM 1162 1171	rituximab
#21	AnnotatorNotes T29	C0393022; rituximab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T30	CHEM 1173 1184	tocilizumab
#22	AnnotatorNotes T30	C1609165; tocilizumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T31	PROC 1395 1419	consentimiento informado
#23	AnnotatorNotes T31	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T32	DISO 1490 1492	AR
#24	AnnotatorNotes T32	C0003873; Rheumatoid Arthritis; Disease or Syndrome
T33	DISO 1524 1550	manifestaciones sistémicas
T34	PROC 1581 1598	terapia biológica
#25	AnnotatorNotes T34	C0005527; Biological Response Modifier Therapy; Therapeutic or Preventive Procedure
T35	DISO 1620 1646	manifestaciones sistémicas
T36	DISO 1664 1666	AR
#26	AnnotatorNotes T36	C0003873; Rheumatoid Arthritis; Disease or Syndrome
T37	PROC 1736 1754	evaluación clínica
#27	AnnotatorNotes T37	C4534461; Clinical assessment; Health Care Activity
T38	DISO 1769 1781	fibromialgia
#28	AnnotatorNotes T38	C0016053; Fibromyalgia; Disease or Syndrome
T39	DISO 1802 1833	enfermedad inflamatoria crónica
#29	AnnotatorNotes T39	C1290886; Chronic inflammatory disorder; Disease or Syndrome
T40	PROC 1851 1892	tratamiento crónico con terapia biológica
T41	PROC 1927 1946	pautas de reducción
#30	AnnotatorNotes T41	C2348004; Agent Dose Decreased; Therapeutic or Preventive Procedure (?)
T42	PROC 1993 2008	pautas de dosis
T43	DISO 1679 1688	patología
#31	AnnotatorNotes T43	C0677042; Pathology processes; Pathologic Function
T44	Date 13 17	2012
T45	LIVB 105 114	pacientes
#32	AnnotatorNotes T45	C0030705; Patients; Patient or Disabled Group
T46	LIVB 336 345	pacientes
#33	AnnotatorNotes T46	C0030705; Patients; Patient or Disabled Group
T47	LIVB 572 581	pacientes
#34	AnnotatorNotes T47	C0030705; Patients; Patient or Disabled Group
T48	LIVB 793 802	pacientes
#35	AnnotatorNotes T48	C0030705; Patients; Patient or Disabled Group
T49	LIVB 913 922	Pacientes
#36	AnnotatorNotes T49	C0030705; Patients; Patient or Disabled Group
T50	Age 923 941	mayores de 18 años
T51	LIVB 945 954	Pacientes
#37	AnnotatorNotes T51	C0030705; Patients; Patient or Disabled Group
T52	Date 1034 1038	1987
T53	LIVB 1042 1051	Pacientes
#38	AnnotatorNotes T53	C0030705; Patients; Patient or Disabled Group
T54	LIVB 1236 1245	Pacientes
#39	AnnotatorNotes T54	C0030705; Patients; Patient or Disabled Group
T55	Duration 1320 1339	los últimos 6 meses
T56	LIVB 1369 1378	Pacientes
#40	AnnotatorNotes T56	C0030705; Patients; Patient or Disabled Group
T57	LIVB 1476 1485	Pacientes
#41	AnnotatorNotes T57	C0030705; Patients; Patient or Disabled Group
T58	LIVB 1650 1659	Pacientes
#42	AnnotatorNotes T58	C0030705; Patients; Patient or Disabled Group
T59	LIVB 1759 1767	paciente
#43	AnnotatorNotes T59	C0030705; Patients; Patient or Disabled Group
T60	Duration 1826 1833	crónica
#44	AnnotatorNotes T60	C0205191; chronic; Temporal Concept
T61	LIVB 1838 1847	Pacientes
#45	AnnotatorNotes T61	C0030705; Patients; Patient or Disabled Group
T62	Duration 1863 1870	crónico
#46	AnnotatorNotes T62	C0205191; chronic; Temporal Concept
T63	LIVB 1971 1989	grupo experimental
#47	AnnotatorNotes T63	C1320290; Experimental Group; Population Group
T65	LIVB 2046 2064	grupo experimental
#48	AnnotatorNotes T65	C1320290; Experimental Group; Population Group
T66	PROC 81 101	disminución de dosis
#49	AnnotatorNotes T66	C2348004; Agent Dose Decreased; Therapeutic or Preventive Procedure
T67	PROC 312 332	disminución de dosis
#50	AnnotatorNotes T67	C2348004; Agent Dose Decreased; Therapeutic or Preventive Procedure
T68	PROC 548 568	disminución de dosis
#51	AnnotatorNotes T68	C2348004; Agent Dose Decreased; Therapeutic or Preventive Procedure
T69	PROC 769 789	disminución de dosis
#52	AnnotatorNotes T69	C2348004; Agent Dose Decreased; Therapeutic or Preventive Procedure
T64	Quantifier_or_Qualifier 1360 1365	basal
#53	AnnotatorNotes T64	C1442488; Baseline; Quantitative Concept
T70	PROC 1353 1359	visita
#54	AnnotatorNotes T70	C1512346; Patient Visit; Health Care Activity
#55	AnnotatorNotes T11	C1709323; Open Label Study; Research Activity + C0206035; Controlled Clinical Trials, Randomized; Research Activity
#56	AnnotatorNotes T5	C0005527; Biological Response Modifier Therapy; Therapeutic or Preventive Procedure
#57	AnnotatorNotes T10	C0005527; Biological Response Modifier Therapy; Therapeutic or Preventive Procedure
#58	AnnotatorNotes T19	C0005527; Biological Response Modifier Therapy; Therapeutic or Preventive Procedure
#59	AnnotatorNotes T15	C0005527; Biological Response Modifier Therapy; Therapeutic or Preventive Procedure
#60	AnnotatorNotes T22	C0005527; Biological Response Modifier Therapy; Therapeutic or Preventive Procedure
R1	Experiences Arg1:T45 Arg2:T66	
R2	Experiences Arg1:T45 Arg2:T3	
R3	Experiences Arg1:T45 Arg2:T4	
R4	Experiences Arg1:T45 Arg2:T5	
R5	Before Arg1:T5 Arg2:T66	
T71	Observation 147 163	remisión clínica
#61	AnnotatorNotes T71	C0544452; Disease remission; Finding
R6	Before Arg1:T3 Arg2:T71	
R7	Before Arg1:T4 Arg2:T71	
R8	Experiences Arg1:T45 Arg2:T71	
T72	Observation 378 394	remisión clínica
#62	AnnotatorNotes T72	C0544452; Disease remission; Finding
R9	Before Arg1:T8 Arg2:T72	
R10	Before Arg1:T9 Arg2:T72	
R11	Experiences Arg1:T46 Arg2:T67	
R12	Experiences Arg1:T46 Arg2:T8	
R13	Experiences Arg1:T46 Arg2:T9	
R14	Experiences Arg1:T46 Arg2:T72	
R15	Experiences Arg1:T46 Arg2:T10	
R16	Before Arg1:T10 Arg2:T67	
T73	Quantifier_or_Qualifier 395 406	persistente
#63	AnnotatorNotes T73	C0205322; Persistent; Temporal Concept
R17	Has_Quantifier_or_Qualifier Arg1:T72 Arg2:T73	
R18	Experiences Arg1:T47 Arg2:T68	
R19	Experiences Arg1:T47 Arg2:T14	
R20	Experiences Arg1:T47 Arg2:T15	
R21	Before Arg1:T15 Arg2:T68	
T74	Observation 609 617	remisión
#64	AnnotatorNotes T74	C0544452; Disease remission; Finding
R22	Before Arg1:T14 Arg2:T74	
R23	Experiences Arg1:T47 Arg2:T74	
R24	Experiences Arg1:T48 Arg2:T69	
R25	Experiences Arg1:T48 Arg2:T18	
R26	Experiences Arg1:T48 Arg2:T19	
R27	Before Arg1:T19 Arg2:T69	
T75	Observation 830 846	remisión clínica
#65	AnnotatorNotes T75	C0544452; Disease remission; Finding
R28	Before Arg1:T18 Arg2:T75	
R29	Experiences Arg1:T48 Arg2:T75	
R30	Has_Age Arg1:T49 Arg2:T50	
R31	Experiences Arg1:T51 Arg2:T20	
R32	Experiences Arg1:T51 Arg2:T21	
T76	CONC 994 1030	criterios de clasificación de la ACR
R33	Experiences Arg1:T53 Arg2:T22	
R34	Used_for Arg1:T23 Arg2:T22	
R35	Used_for Arg1:T24 Arg2:T22	
R36	Used_for Arg1:T25 Arg2:T22	
R37	Used_for Arg1:T26 Arg2:T22	
R38	Used_for Arg1:T27 Arg2:T22	
R39	Used_for Arg1:T28 Arg2:T22	
R40	Used_for Arg1:T29 Arg2:T22	
R41	Used_for Arg1:T30 Arg2:T22	
T77	Observation 1204 1220	remisión clínica
#66	AnnotatorNotes T77	C0544452; Disease remission; Finding
R42	Experiences Arg1:T53 Arg2:T77	
R43	Overlap Arg1:T22 Arg2:T77	
T78	Quantifier_or_Qualifier 1221 1232	establecida
#67	AnnotatorNotes T78	C0443211; Established; Qualitative Concept
R44	Has_Quantifier_or_Qualifier Arg1:T77 Arg2:T78	
T79	Observation 1259 1267	remisión
#68	AnnotatorNotes T79	C0544452; Disease remission; Finding
R45	Experiences Arg1:T54 Arg2:T79	
T80	CONC 1285 1290	DAS28
#69	AnnotatorNotes T80	C2732493; Disease activity score 28 joint in rheumatoid arthritis; Intellectual Product
T81	Result_or_Value 1290 1294	<2.4
R46	Has_Result_or_Value Arg1:T80 Arg2:T81	
T82	CONC 1302 1306	SDAI
#70	AnnotatorNotes T82	C3869582; Simplified disease activity index; Intellectual Product
T83	Result_or_Value 1306 1310	<3.3
R47	Has_Result_or_Value Arg1:T82 Arg2:T83	
R48	Has_Duration_or_Interval Arg1:T79 Arg2:T55	
R49	Overlap Arg1:T80 Arg2:T55	
R50	Overlap Arg1:T82 Arg2:T55	
R51	Before Arg1:T79 Arg2:T70	
R52	Before Arg1:T80 Arg2:T70	
R53	Before Arg1:T82 Arg2:T70	
R54	Has_Quantifier_or_Qualifier Arg1:T70 Arg2:T64	
R55	Experiences Arg1:T54 Arg2:T80	
T84	Observation 1422 1446	participar en el estudio
#71	AnnotatorNotes T84	C1278516; Patient participation status; Finding
R56	Before Arg1:T31 Arg2:T84	
R57	Experiences Arg1:T57 Arg2:T32	
R58	Experiences Arg1:T57 Arg2:T33	
R59	Causes Arg1:T32 Arg2:T33	
R60	Experiences Arg1:T57 Arg2:T34	
R61	Experiences Arg1:T57 Arg2:T35	
R62	Causes Arg1:T32 Arg2:T35	
R63	Experiences Arg1:T58 Arg2:T36	
R64	Overlap Arg1:T36 Arg2:T43	
R65	Experiences Arg1:T58 Arg2:T43	
R66	Experiences Arg1:T58 Arg2:T37	
R67	Experiences Arg1:T58 Arg2:T38	
R68	Experiences Arg1:T58 Arg2:T39	
R69	Has_Duration_or_Interval Arg1:T39 Arg2:T60	
R70	Overlap Arg1:T36 Arg2:T38	
R71	Overlap Arg1:T36 Arg2:T39	
R72	Experiences Arg1:T59 Arg2:T36	
R73	Experiences Arg1:T59 Arg2:T43	
R74	Experiences Arg1:T59 Arg2:T38	
R75	Experiences Arg1:T59 Arg2:T37	
T85	Observation 1711 1754	dificulte o modifique la evaluación clínica
R76	Causes Arg1:T43 Arg2:T85	
R78	Causes Arg1:T38 Arg2:T85	
R79	Causes Arg1:T39 Arg2:T85	
R80	Has_Duration_or_Interval Arg1:T40 Arg2:T62	
R81	Experiences Arg1:T61 Arg2:T40	
R82	Experiences Arg1:T61 Arg2:T41	
R83	Before Arg1:T40 Arg2:T41	
R84	Experiences Arg1:T63 Arg2:T40	
R85	Experiences Arg1:T63 Arg2:T41	
R86	Experiences Arg1:T65 Arg2:T40	
R87	Experiences Arg1:T65 Arg2:T41	
R88	Experiences Arg1:T63 Arg2:T42	
R89	Experiences Arg1:T61 Arg2:T42	
R90	Experiences Arg1:T65 Arg2:T42	
T86	CONC 2083 2092	inclusión
#72	AnnotatorNotes T86	C1512693; Inclusion; Qualitative Concept
R91	Before Arg1:T41 Arg2:T86	
R92	Before Arg1:T42 Arg2:T86	
T87	Quantifier_or_Qualifier 2009 2016	menores
#73	AnnotatorNotes T87	C0205165; Minor (value); Qualitative Concept
R93	Has_Quantifier_or_Qualifier Arg1:T42 Arg2:T87	
T88	Quantifier_or_Qualifier 2019 2033	más espaciadas
R94	Has_Quantifier_or_Qualifier Arg1:T42 Arg2:T88	
#74	AnnotatorNotes T42	C4684645; Dosage Regimen; Therapeutic or Preventive Procedure
R77	Experiences Arg1:T59 Arg2:T39	
R95	Experiences Arg1:T54 Arg2:T70	
A1	Experiencer T45 Patient
A2	Experiencer T46 Patient
A3	Experiencer T47 Patient
A4	Experiencer T48 Patient
A5	Experiencer T49 Patient
A6	Experiencer T51 Patient
A7	Experiencer T53 Patient
A8	Experiencer T54 Patient
A9	Experiencer T56 Patient
A10	Experiencer T57 Patient
A11	Experiencer T58 Patient
A12	Experiencer T59 Patient
A13	Experiencer T61 Patient
A14	Experiencer T63 Patient
A15	Experiencer T65 Patient
